Literature DB >> 8894196

Impulsivity or comorbidity in bulimia nervosa. A controlled study of deliberate self-harm and alcohol and drug misuse in a community sample.

S L Welch1, C G Fairburn.   

Abstract

BACKGROUND: Studies showing high rates of alcohol and drug misuse and deliberate self-harm in bulimia nervosa have led some authors to call for a distinct diagnostic subgroup, sometimes termed "multi-impulsive bulimia". However, these studies have been uncontrolled and of clinic samples and may be subject to sampling bias.
METHOD: One hundred and two women with DSM-III-R bulimia nervosa were compared with 204 normal controls and 102 controls with other psychiatric disorders, all recruited from the same community sample. Interview measures were used for diagnosis and for the assessment of alcohol and drug misuse and deliberate self-harm.
RESULTS: Bulimia nervosa cases did not differ from either of the control groups in terms of current alcohol consumption. Bulimia nervosa cases used more illicit drugs than either control group, but loss of control over drug use was very uncommon. Bulimia nervosa cases had a higher rate of deliberate self-harm than the controls. Only six (6%) bulimia nervosa cases had two or more of these behaviours concurrently.
CONCLUSION: Sampling bias is present in clinic-based studies of comorbidity in bulimia nervosa. Those with comorbid substance misuse and deliberate self-harm are probably heterogeneous in character, and their classification as a subgroup would therefore be premature.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894196     DOI: 10.1192/bjp.169.4.451

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  10 in total

1.  Somatic problems and self-injurious behaviour 18 years after teenage-onset anorexia nervosa.

Authors:  Elisabet Wentz; I Carina Gillberg; Henrik Anckarsäter; Christopher Gillberg; Maria Råstam
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-04-07       Impact factor: 4.785

2.  Is there a relationship between Internet dependence and eating disorders? A comparison study of Internet dependents and non-Internet dependents.

Authors:  Z L Tao; Y Liu
Journal:  Eat Weight Disord       Date:  2009 Jun-Sep       Impact factor: 4.652

3.  Pathways Between Concealable Stigmatized Identities and Substance Misuse.

Authors:  Amelia E Talley; Andrew K Littlefield
Journal:  Soc Personal Psychol Compass       Date:  2014-10

Review 4.  Alternative methods of classifying eating disorders: models incorporating comorbid psychopathology and associated features.

Authors:  Jennifer E Wildes; Marsha D Marcus
Journal:  Clin Psychol Rev       Date:  2013-01-26

5.  Psychopathological distress predicts suicidal ideation and self-harm in adolescent eating disorder outpatients.

Authors:  Jaana Ruuska; Riittakerttu Kaltiala-Heino; Päivi Rantanen; Anna-Maija Koivisto
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-08       Impact factor: 4.785

6.  Eating disorder symptomatology and substance use disorders: prevalence and shared risk in a population based twin sample.

Authors:  Jessica H Baker; Karen S Mitchell; Michael C Neale; Kenneth S Kendler
Journal:  Int J Eat Disord       Date:  2010-11-01       Impact factor: 4.861

Review 7.  Cognitive-behavioural therapy for individuals with bulimia nervosa and a co-occurring substance use disorder.

Authors:  Robyn Sysko; Tom Hildebrandt
Journal:  Eur Eat Disord Rev       Date:  2009-03

8.  A cross-lagged evaluation of eating disorder symptomatology and substance-use problems.

Authors:  Erin C Dunn; Clayton Neighbors; Nicole Fossos; Mary E Larimer
Journal:  J Stud Alcohol Drugs       Date:  2009-01       Impact factor: 2.582

9.  Bulimia Nervosa: A Primary Care Review.

Authors:  Jona M. Rushing; Laura E. Jones; Caroline P. Carney
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-10

10.  Characteristics of suicide attempts in anorexia and bulimia nervosa: a case-control study.

Authors:  Sébastien Guillaume; Isabelle Jaussent; Emilie Olié; Catherine Genty; Jacques Bringer; Philippe Courtet; Ulrike Schmidt
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.